| Literature DB >> 35531197 |
Bassam Abomoelak1, Samani U Pragya2, Anthony J Griswold3, Neelam Mehta4, Parvin Uddin5, Pushya Veeramachaneni6, Naina Mehta1, Samani C Pragya7, Hesham A El Enshasy8,9, Devendra Mehta1.
Abstract
Background: The human transcriptome across a variety of cell types and tissues are affected by stress and other psychological factors. Preksha Dhyana meditation (PM) is effective at improving cognitive skills in novice healthy college student meditators after 8 weeks of intervention, but the molecular and cellular mechanisms involved in these improvements are still largely unknown.Entities:
Keywords: Cellular pathways; Preksha Dhyana; Transcriptome; Up-and down-regulated genes
Year: 2021 PMID: 35531197 PMCID: PMC9072888 DOI: 10.1016/j.sjbs.2021.11.060
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.052
Fig. 1Supervised heatmap of the significantly and differentially expressed genes between the baseline and 8 weeks post-intervention. The figure depicts the 494 affected genes (Y-axis) in the 36 samples (X-axis). The color key shows the scale of regulation (-4 to 4), and green color denotes the upregulation while the red color denotes the downregulation.
The list of the 20 most upregulated genes in the study.
| Ensembl_ID | Gene_name | logFC | linearFC | logCPM | P-Value |
|---|---|---|---|---|---|
| ENSG00000163492.9 | CCDC141 | 1.74E+00 | 3.33E+00 | 1.13E+00 | 1.26E−02 |
| ENSG00000178404.5 | DDC8 | 1.65E+00 | 3.14E+00 | 1.83E+00 | 2.22E−03 |
| ENSG00000155657.19 | TTN | 1.30E+00 | 2.46E+00 | 4.86E+00 | 2.58E−02 |
| ENSG00000078114.14 | NEBL | 1.28E+00 | 2.44E+00 | 5.36E−01 | 1.59E−02 |
| ENSG00000124575.5 | HIST1H1D | 1.22E+00 | 2.33E+00 | 7.72E−01 | 9.62E−03 |
| ENSG00000042832.7 | TG | 1.21E+00 | 2.31E+00 | 1.38E+00 | 5.36E−05 |
| ENSG00000115239.17 | GPR75-ASB3 | 1.20E+00 | 2.30E+00 | 2.71E−02 | 1.04E−02 |
| ENSG00000213132.2 | AC022498.1 | 1.19E+00 | 2.28E+00 | 8.68E−01 | 1.80E−03 |
| ENSG00000008086.6 | CDKL5 | 1.18E+00 | 2.27E+00 | 6.10E−01 | 2.01E−02 |
| ENSG00000197580.7 | BCO2 | 1.14E+00 | 2.20E+00 | 5.12E−02 | 1.41E−02 |
| ENSG00000164082.10 | GRM2 | 1.13E+00 | 2.18E+00 | 3.27E−01 | 4.77E−03 |
| ENSG00000169031.14 | COL4A3 | 1.10E+00 | 2.14E+00 | 5.21E−01 | 5.04E−03 |
| ENSG00000198518.5 | HIST1H4E | 1.05E+00 | 2.07E+00 | 1.49E+00 | 3.73E−02 |
| ENSG00000160229.7 | ZNF66 | 9.36E−01 | 1.91E+00 | 9.87E−01 | 8.18E−03 |
| ENSG00000181722.11 | ZBTB20 | 9.36E−01 | 1.91E+00 | 2.49E+00 | 4.31E−02 |
| ENSG00000130997.12 | POLN | 9.25E−01 | 1.90E+00 | 1.91E−01 | 2.90E−02 |
| ENSG00000176438.8 | SYNE3 | 9.12E−01 | 1.88E+00 | 3.33E+00 | 1.13E−03 |
| ENSG00000081052.10 | COL4A4 | 8.87E−01 | 1.85E+00 | 5.02E−01 | 8.81E−03 |
| ENSG00000188167.4 | TMPPE | 8.82E−01 | 1.84E+00 | 2.41E+00 | 2.18E−02 |
| ENSG00000212743.1 | DKFZP667F0711 | 8.77E−01 | 1.84E+00 | 1.60E+00 | 1.00E−02 |
The list of the 20 most downregulated genes in the study.
| Ensembl_ID | Gene_name | logFC | linearFC | logCPM | p-value |
|---|---|---|---|---|---|
| ENSG00000125618.12 | PAX8 | −1.33E+00 | −2.52E+00 | 7.26E−01 | 7.64E−03 |
| ENSG00000089685.10 | BIRC5 | −1.09E+00 | −2.13E+00 | 1.18E+00 | 1.07E−02 |
| ENSG00000182272.7 | B4GALNT4 | −1.09E+00 | −2.12E+00 | 5.01E−01 | 4.40E−02 |
| ENSG00000134321.7 | RSAD2 | −1.08E+00 | −2.11E+00 | 5.37E+00 | 1.17E−02 |
| ENSG00000112290.8 | WASF1 | −1.07E+00 | −2.10E+00 | 2.82E−02 | 7.83E−03 |
| ENSG00000154165.3 | GPR15 | −1.06E+00 | −2.08E+00 | 6.63E−02 | 8.67E−03 |
| ENSG00000165949.8 | IFI27 | −1.05E+00 | −2.07E+00 | 3.45E+00 | 2.96E−02 |
| ENSG00000137807.9 | KIF23 | −1.04E+00 | −2.05E+00 | 4.71E−01 | 1.97E−02 |
| ENSG00000241043.1 | GVQW1 | −1.04E+00 | −2.05E+00 | 2.34E−01 | 4.19E−02 |
| ENSG00000075218.14 | GTSE1 | −1.02E+00 | −2.03E+00 | 1.43E−01 | 1.53E−02 |
| ENSG00000177469.12 | PTRF | −9.91E−01 | −1.99E+00 | 4.51E−02 | 2.92E−02 |
| ENSG00000124019.9 | FAM124B | −9.39E−01 | −1.92E+00 | 1.23E−01 | 2.72E−02 |
| ENSG00000165244.6 | ZNF367 | −9.39E−01 | −1.92E+00 | 7.26E−01 | 7.99E−03 |
| ENSG00000029993.10 | HMGB3 | −9.11E−01 | −1.88E+00 | 5.15E−01 | 8.49E−03 |
| ENSG00000105991.7 | HOXA1 | −9.11E−01 | −1.88E+00 | 2.63E−01 | 1.45E−02 |
| ENSG00000135047.10 | CTSL | −8.91E−01 | −1.85E+00 | 2.66E+00 | 1.51E−04 |
| ENSG00000171766.11 | GATM | −8.86E−01 | −1.85E+00 | 4.58E−01 | 1.59E−02 |
| ENSG00000172426.11 | RSPH9 | −8.86E−01 | −1.85E+00 | 8.23E−01 | 4.67E−03 |
| ENSG00000141682.11 | PMAIP1 | −8.83E−01 | −1.84E+00 | 1.82E+00 | 5.79E−03 |
| ENSG00000134548.5 | C12orf39 | −8.82E−01 | −1.84E+00 | 1.02E+00 | 1.48E−02 |
The affected canonical pathways when upregulated (A) and downregulated (B) genes were used in Ingenuity pathway analysis.
| Name of pathway | p-value | Overlap |
|---|---|---|
Top Canonical Pathways | ||
| Anandamide Degradation | 1.75E−02 | 33.3% (1/3 |
| Transcriptional Regulatory Network in Embryonic Stem Cells | 4.00E−02 | 3.7% (2/54 |
| Phosphatidylcholine Biosynthesis I | 4.03E−02 | 14.3% (1/7) |
| Phosphatidylethanolamine Biosynthesis II | 5.15E−02 | 11.1% (1/9) |
| NAD Phosphorylation and Dephosphorylation | 7.36E−02 | 7.7% (1/13) |
Top Canonical Pathways | ||
| Interferon Signaling | 1.82E−05 | 16.7% (6/36) |
| Th1 and Th2 Activation Pathway | 8.64E−05 | 6.4% (11/172) |
| Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I | 3.42E−04 | 18.2% (4/22) |
| Prolactin Signaling | 1.68E−03 | 7.4% (6/81) |
| Unfolded protein response | 1.79E−03 | 8.9% (5/56) |